Copernicus Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $850K | Buy |
+11,000
| New | +$850K | 10.29% | 4 |
|
|
2021
Q2 | – | Sell |
-10,000
| Closed | -$755K | – | 14 |
|
|
2021
Q1 | $755K | Sell |
10,000
-719
| -7% | -$54.3K | 12.2% | 1 |
|
|
2020
Q4 | $940K | Sell |
10,719
-154,462
| -94% | -$13.5M | 14.65% | 1 |
|
|
2020
Q3 | $12.6M | Buy |
165,181
+115,292
| +231% | +$8.77M | 11.97% | 3 |
|
|
2020
Q2 | $6.15M | Sell |
49,889
-53,290
| -52% | -$6.57M | 6.74% | 6 |
|
|
2020
Q1 | $8.72M | Sell |
103,179
-20,779
| -17% | -$1.76M | 10.55% | 4 |
|
|
2019
Q4 | $10.5M | Sell |
123,958
-12,042
| -9% | -$1.02M | 13.74% | 2 |
|
|
2019
Q3 | $9.17M | Buy |
+136,000
| New | +$9.17M | 8.53% | 5 |
|